Vera Therapeutics News

Vera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Joseph R

Apr 12 16:03 ET

Vera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grant Sean

Apr 5 21:34 ET

Vera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grant Sean

Apr 5 21:29 ET

Vera Therapeutics | ARS: Annual Report to Security Holders

Apr 4 06:05 ET

Vera Therapeutics | DEF 14A: Definitive information statements

Apr 3 17:04 ET

Vera Therapeutics | DEFA14A: Others

Apr 3 17:04 ET

Vera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 3 16:22 ET

Vera Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 27 16:21 ET

Vera Therapeutics | 10-K: Annual report

Mar 27 14:53 ET

Vera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dr. Maha Katabi (“Katabi”)(5.4%),Sofinnova Venture Partners X, L.P. (“SVP X”)(5.3%), etc.

Mar 26 20:00 ET

Vera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Katabi Maha

Mar 25 21:50 ET

Vera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 21 16:58 ET

Vera Therapeutics | 8-K: Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 20 07:32 ET

Vera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sofinnova Venture Partners X, L.P. (“SVP X”)(6.9%),Sofinnova Management X, L.P. (“SM X LP”)(6.9%), etc.

Feb 20 19:15 ET

Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(11.3%),Commodore Capital Master LP(11.3%)

Feb 14 18:06 ET

Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(12.3%),Commodore Capital Master LP(12.3%)

Feb 14 18:00 ET

Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Securities LLC(0.1%),Citadel Securities Group LP(0.1%), etc.

Feb 14 17:04 ET

Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ares Trading SA(3.6%),Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany(3.6%), etc.

Feb 14 15:25 ET

Vera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kynam Capital Management, LP(8.22%),Kynam Capital Management GP, LLC(8.22%), etc.

Feb 14 12:52 ET

Vera Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Woodline Partners LP(2.2%)

Feb 12 16:43 ET